Evidence map›Paper›PMID 33337348›Full record

ArticleCancer biomarkers : section A of Disease markers2021

MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma.

Thomas J Kalantzakos, Travis B Sullivan, Luke E Sebel, David Canes, Eric J Burks, Alireza Moinzadeh, Kimberly M Rieger-Christ

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas J KalantzakosDepartment of Translational Research, Lahey Hospital and Medical Center, Burlington, MA, USA.
Travis B SullivanDepartment of Translational Research, Lahey Hospital and Medical Center, Burlington, MA, USA.
Luke E SebelDepartment of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA.
David CanesDepartment of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA.
Eric J BurksDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Alireza MoinzadehDepartment of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA.
Kimberly M Rieger-ChristDepartment of Translational Research, Lahey Hospital and Medical Center, Burlington, MA, USA.
Lahey Hospital and Medical Center · USBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroRNAs (miRNAs), a group of non-coding post-transcriptional regulators of gene expression, are dysregulated in clear cell renal cell carcinoma (ccRCC) and play an important role in carcinogenesis. Our prior work identified a subset of miRNAs in pT1 ccRCC tumors associated with progression to metastatic disease.

objectiveTo investigate the impact of two of these dysregulated miRNA, miR-15a-5p and -26a-5p, in an effort to elucidate the mechanisms underpinning aggressive forms of stage I ccRCC.

methodsThe ccRCC cell line 786-O was transfected with pre-miRs-15a-5p and -26a-5p to rescue expression. Cell proliferation was measured via MT Cell Viability Assay. O-GlcNAc-transferase (OGT), a known protein in ccRCC proliferation, was identified by bioinformatics analysis as a target of both miRNA and validated via luciferase reporter assay to confirm binding of each miR to the 3' untranslated region (UTR). OGT protein expression was evaluated via western blotting.

resultsLuciferase assay confirmed specificity of miR-15a-5p and -26a-5p for the OGT UTR. Western blot analysis for OGT showed reduced expression following co-transfection of both miRNAs compared to negative control or individual transfection. Co-transfection of these miRNAs greatly reduced proliferation when compared to negative control or the individual transfections.

conclusionOur results indicate that the dysregulation of miR-15a-5p and -26a-5p contribute cooperatively to the proliferation of ccRCC through their regulation of OGT. These results give insight into the pathogenesis of aggressive early stage ccRCC and suggest potential therapeutic targets for future research.

Indexed as

Carcinoma, Renal CellCell ProliferationHumansKidney NeoplasmsMicroRNAsN-AcetylglucosaminyltransferasesTransfectionMicroRNAsMIRN15 microRNA, humanMIRN26 microRNA, humanN-AcetylglucosaminyltransferasesO-GlcNAc transferaseBiomarkersclear cell renal cell cancer (ccRCC)microRNAO-GlcNAc-transferase (OGT)proliferation

Identifiers

PMID33337348
PMCPMC12499970
OpenAlexW3112843937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.